Interim Safety And Efficacy Results Of The Abi-H0731 Phase 2a Program Exploring The Combination Of Abi-H0731 With Nuc Therapy In Treatment-Naive And Treatment-Suppressed Chronic Hepatitis B Patients

JOURNAL OF HEPATOLOGY(2019)

Cited 26|Views53
No score
Key words
nuc therapy,efficacy results,treatment-naive,treatment-suppressed
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined